• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov15
Achilles Therapeutics released FY2024 Cumulative 3Q Earnings on November 14 (EST), Revenue: 0, EPS: -1.1952
04:00
Achilles Therapeutics released FY2024 Q3 earnings on November 14 (EST), actual revenue 0 USD (forecast 0 USD), actual EPS -0.4846 USD (forecast -0.455 USD)
04:00

Schedules & Filings

Schedules
Filings
Nov14
Earning Release(EST)

FY2024 Q3 Earning Release (USD) Net Income -19.6 M, EPS -0.4846

Aug14
Earning Release(EST)

FY2024 Q2 Earning Release (USD) Net Income -16.38 M, EPS -0.4058

May8
Earning Release(EST)

FY2024 Q1 Earning Release (USD) Net Income -12.27 M, EPS -0.3047

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
FJET
31.500
+370.85%
+24.810
HXHX
1.290
+273.91%
+0.945
SIDU
2.290
+97.41%
+1.130
MGRT
12.440
+70.41%
+5.140
MENS
4.780
+50.55%
+1.605
HYMC
24.520
+49.33%
+8.100
VELO
15.590
+43.95%
+4.760
QBTX
51.760
+39.25%
+14.590
CMCT
4.310
+35.11%
+1.120
FLYT
22.750
+32.81%
+5.620
View More